How to Buy Finch Therapeutics Group Stock
Finch Therapeutics Group Inc
Finch Therapeutics Group, Inc. , a clinical-stage microbiome therapeutics company, develops a novel class of orally administered biological drugs in the United States.
Finch Therapeutics Group stock last closed at $0.30, up 3.82% from the previous day, and has decreased 87.54% in one year. It has underperformed other stocks in the Biotechnology industry by 0.75 percentage points. Finch Therapeutics Group stock is currently +19.12% from its 52-week low of $0.25, and -90.03% from its 52-week high of $3.00.
At the moment, there are 48.14M FNCH shares outstanding. The market value of FNCH is $14.40M. In the past 24 hours, 41,042 FNCH shares were traded.
How to Buy Finch Therapeutics Group Stock
Not sure how to invest in Finch Therapeutics Group stock? Here's how.
- Decide where to buy Finch Therapeutics Group stock: You need to choose a stock brokerage, but don't worry - we've analyzed dozens of online brokerages and apps to help you determine where to buy Finch Therapeutics Group stock.
- Open a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've selected.
- Deposit funds into your brokerage account: Choose your payment method and add your information.
- Analyze Finch Therapeutics Group stock: The Finch Therapeutics Group ticker symbol is FNCH. Is Finch Therapeutics Group stock a good investment? Should you buy shares of FNCH? How do FNCH's underlying business fundamentals look? Do top analysts think Finch Therapeutics Group is a good buy? Why has FNCH's stock price moved recently? (Hint: Our stock market analysis tools can help you figure out if FNCH is a good stock to buy).
- Place your FNCH trade: Decide if you will purchase FNCH shares at the current market price or use a limit order to buy FNCH shares at a specific price.
- Keep tabs on your investment in FNCH: Create a watchlist to get live updates on your position in Finch Therapeutics Group stock.
Step 1: Decide where to buy Finch Therapeutics Group stock
You will need a brokerage account in order to access the NASDAQ market and buy FNCH stock.
Our recommended brokerage: eToro
We believe that eToro is the best online stock brokerage. eToro gives you:
- Invest in stocks with 0% commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still buy the stock.
- Access to global financial markets: From Tech to Utilities, New York to Shanghai — you can fill your portfolio with stocks from the world's leading stock exchanges.
- Social investing: eToro boasts a community of more than 20 million users around the world. Talk to, learn from, and copy the crypto trades of other investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other assets: Such as ETFs and cryptos.
Get $10 towards your purchase of shares by creating an account with eToro now.
Open eToro AccountStep 2: Open a brokerage account
Now that you've chosen your brokerage, you'll need to fill out some personal details so you are able to buy FNCH stock today.
How to Create a New Account on eToro
- Click here to get started.
- Input your personal info to create a new brokerage account.
- Send your application by clicking the "Create Account" button.
Step 3: Deposit funds into your brokerage account
Now that you've created your account on our top ranked stock market app, your next step is to transfer the money for your investment:
Watch this video walkthrough if you need help depositing funds into your new investment account.
Step 4: Analyze Finch Therapeutics Group stock
Once you have figured out the best place to buy Finch Therapeutics Group stock, it's very important to research their stock before you invest, so you actually understand the risk as well as the upside.
Finch Therapeutics Group Metrics
Finch Therapeutics Group Zen Score
WallStreetZen was created to help average investors perform better fundamental analysis.
You can see all of the due diligence checks on FNCH's stock page.
How is FNCH stock valued?
You can use many financial metrics, analyses, models, and charts to gauge FNCH's intrinsic value.
Using relative valuations metrics:
- FNCH could be undervalued based on its P/B ratio of 0.44x, relative to Biotechnology industry P/B ratio of 5.2x
You can do additional valuation analysis on FNCH's stock here.
FNCH Financial Overview
Passed Health Checks:
- There are more short-term assets than short-term liabilities on the FNCH balance sheet.
- There are more short-term assets than long-term liabilities on the FNCH balance sheet.
Failed Health Checks:
- FNCH has a relatively high debt to equity ratio of 1.4.
- FNCH profit margin has gone down from -448.4% to -25,084.4% in the past year.
- FNCH has cash burn of 63873000. It does not have enough cash and short-term investments to cover this.
- FNCH has $41.68M in cash and short term investments. This is not enough to cover its annual cash burn of $63.87M.
Is it a good time to buy Finch Therapeutics Group stock, according to analysts?
Out of 1 Equities analysts who monitor FNCH, the consensus analyst rating on FNCH is a Buy
Please keep in mind that analyst ratings are not recommendations, nor are they financial advice.
Latest FNCH Analyst Ratings
Vernon Bernardino, a top 16% analyst from HC Wainwright & Co. reiterates FNCH with a buy rating and maintains their FNCH price target from $7.00 to $7.00, on May 12, 2023.
You can dig deeper into what analysts are forecasting on the Finch Therapeutics Group stock forecast page.
FNCH Trading Indicators
FNCH Earnings
Last year, FNCH revenue was $614.00k. During the past two year, FNCH's revenue has increased by -74.55% per year. This was slower than the Biotechnology industry average of 90.44%.
Find out more about FNCH's earnings and revenue performance here.
What are FNCH executives and large shareholders up to?
In the last year, executives and large shareholders at FNCH have sold more shares than they have bought.
Marc Blaustein, Chief Operating Officer of FNCH, was the latest FNCH insider to sell. They sold $1,755.22 worth of FNCH shares on Feb 21, 2023.
Get more info about who owns FNCH stock here.
Can I rely on FNCH as an income stream?
No, Finch Therapeutics Group doesn't provide an income stream by paying out dividends.
FNCH Social Trading Data
One of the major reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to find out what other traders have to say.
Step 5: Place your FNCH trade
You have two primary options:
- Market order: A market order is an order to buy or sell a security at the best available price.
Market orders are usually fine for most investors. - Limit order: A limit order enables you to buy or sell a stock at a specific price (or better).
If you want to be certain you're buying or selling at an exact price, place a limit order.
Click the Open Trade button and eToro will execute your order.
If you want additional help buying stocks on eToro, click the helpful video below:
Step 6: Keep tabs on your investment in FNCH
Now that you own some shares in FNCH, you'll want to stay up-to-date on your new investment.
Start a watchlist to track the latest developments regarding your FNCH stock.
FNCH Feed
How to Buy Stock in Finch Therapeutics Group
To summarize, here are the 6 steps for buying Finch Therapeutics Group stock:
- Decide where to buy Finch Therapeutics Group stock
- Open a brokerage account
- Deposit funds into your brokerage account
- Analyze Finch Therapeutics Group stock
- Place your FNCH trade
- Keep tabs on your investment in FNCH
If you need a brokerage, eToro is our favorite option.
Get Started with eToro TodayIf you want to get notifications regarding your new investment in Finch Therapeutics Group, get started below.
More Articles You Might Enjoy
FAQ
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.